The forum, which will be opened by the Secretary for the Economy, the Government of Catalonia, Andreu Morillas, will include presentations by the president of CataloniaBio, Carlos Buesa, and the director of the capital risk enterprise Bear Stearns Health Innoventures, Fritz B\u00fchler. After the opening, in the morning session, representatives from several companies will give presentations on the contribution of international risk companies to the growth of the biotech sector in Catalonia and in Spain. In the afternoon, the director of the BioRegion of Catalonia will present new initiatives to boost the international promotion of the Catalan biotech sector. <\/p>\n
Presentations by several companies involved in investment and in R+D will also be included in the programme, among these Advancell, Lipotec Group, Salvat Biotech, Neuropharma, Lacer, Cellerix, Palau Pharma, BB Biotech, Bear Stearns Health Innoventures, HBM Bioventures, Life Sciences Partners, Novartis Venture, Widmann Associates and Swiss First Asset Management. <\/p>\n","protected":false},"excerpt":{"rendered":"
On Friday 22 September, the Antoni Caparr\u00f3s Auditorium will host the \u00abBarcelona Biotech Financial F\u00f2rum\u00bb<\/a>. Organized by the business association CataloniaBio<\/a>, the BioRegion of Catalonia <\/a> and BioValley<\/a>, and supported by the PCB and the Consell de BioRegions Europees<\/a>, this event seeks to promote contact between local biotech enterprises and international investors. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-45621","post","type-post","status-publish","format-standard","category-uncategorized"],"acf":[],"yoast_head":"\n